Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor

Utthara Nayar; Jonathan Reichel; Jouliana Sadek; Denise Hernandez-Hopkins; Gunkut Akar; Hufeng Zhou; Michelle A. Sahai; Peter Barelli; Ilaria Guasparri; Jennifer Totonchy; Duane Hassane; Shizuko Sei; Robert H. Shoemaker; J. David Warren; Olivier Elemento; Kenneth M. Kaye; Ethel Cesarman

doi:10.1158/1538-7445.AM2015-4496

Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor

Utthara Nayar, Jonathan Reichel, Jouliana Sadek, Denise Hernandez-Hopkins, Gunkut Akar, Hufeng Zhou, Michelle A. Sahai, Peter Barelli, Ilaria Guasparri, Jennifer Totonchy, Duane Hassane, Shizuko Sei, Robert H. Shoemaker, J. David Warren, Olivier Elemento, Kenneth M. Kaye, Ethel Cesarman

School of Life and Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Clinical Cancer Research
Volume	75
DOIs	https://doi.org/10.1158/1538-7445.AM2015-4496
Publication status	Published - 1 Aug 2015

Access to Document

10.1158/1538-7445.AM2015-4496

Cite this

Nayar, U., Reichel, J., Sadek, J., Hernandez-Hopkins, D., Akar, G., Zhou, H., Sahai, M. A., Barelli, P., Guasparri, I., Totonchy, J., Hassane, D., Sei, S., Shoemaker, R. H., Warren, J. D., Elemento, O., Kaye, K. M., & Cesarman, E. (2015). Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor. Clinical Cancer Research, 75. https://doi.org/10.1158/1538-7445.AM2015-4496

@article{83b721952db2431696bb632b449756ca,

title = "Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor",

author = "Utthara Nayar and Jonathan Reichel and Jouliana Sadek and Denise Hernandez-Hopkins and Gunkut Akar and Hufeng Zhou and Sahai, \{Michelle A.\} and Peter Barelli and Ilaria Guasparri and Jennifer Totonchy and Duane Hassane and Shizuko Sei and Shoemaker, \{Robert H.\} and Warren, \{J. David\} and Olivier Elemento and Kaye, \{Kenneth M.\} and Ethel Cesarman",

year = "2015",

month = aug,

day = "1",

doi = "10.1158/1538-7445.AM2015-4496",

language = "English",

volume = "75",

journal = "Clinical Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

}

Nayar, U, Reichel, J, Sadek, J, Hernandez-Hopkins, D, Akar, G, Zhou, H, Sahai, MA, Barelli, P, Guasparri, I, Totonchy, J, Hassane, D, Sei, S, Shoemaker, RH, Warren, JD, Elemento, O, Kaye, KM & Cesarman, E 2015, 'Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor', Clinical Cancer Research, vol. 75. https://doi.org/10.1158/1538-7445.AM2015-4496

TY - JOUR

T1 - Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor

AU - Nayar, Utthara

AU - Reichel, Jonathan

AU - Sadek, Jouliana

AU - Hernandez-Hopkins, Denise

AU - Akar, Gunkut

AU - Zhou, Hufeng

AU - Sahai, Michelle A.

AU - Barelli, Peter

AU - Guasparri, Ilaria

AU - Totonchy, Jennifer

AU - Hassane, Duane

AU - Sei, Shizuko

AU - Shoemaker, Robert H.

AU - Warren, J. David

AU - Elemento, Olivier

AU - Kaye, Kenneth M.

AU - Cesarman, Ethel

PY - 2015/8/1

Y1 - 2015/8/1

U2 - 10.1158/1538-7445.AM2015-4496

DO - 10.1158/1538-7445.AM2015-4496

M3 - Article

SN - 0008-5472

VL - 75

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -